Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1
Titel:
Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1
Auteur:
Richardson, Paul G. Zimmerman, Todd M. Hofmeister, Craig C. Talpaz, Moshe Chanan-Khan, Asher A. Kaufman, Jonathan L. Laubach, Jacob P. Chauhan, Dharminder Jakubowiak, Andrzej J. Reich, Steven Trikha, Mohit Anderson, Kenneth C.